Literature DB >> 12230289

Analyses of 98 seminoma cases: a review article.

M Güden1, C Ulutin, S Göktas.   

Abstract

98 Patients with seminoma were treated at Clinic of Radiation Oncology of Gülhane Military Medicine Academy between the years 1974-1995. All cases were undergone orchiectomy. The median age of the patients whom were staged respectively 76%, 17%, 7% according to AJCC system, stage I, stage II and stage III was 28 (20-58). While 87 patients were undergone only radiotherapy, 11 patients with advanced stage had taken chemotherapy with radiotherapy. In 52 months of median follow up duration, 5 year disease free survival rates were 98.6%, 93.3%, 25% and 94.5% for stage I, stage II, stage III and all stages respectively. As a result, we can propose that the seminoma is a disease with good results in oncology. In our view detailed staging and new treatment approaches in advanced disease will achieve better results in the future.

Entities:  

Mesh:

Year:  2001        PMID: 12230289     DOI: 10.1023/a:1019502326432

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  7 in total

1.  Tumours of the male urogenital tract: a clinicopathologic study.

Authors:  S Sharma; P Nath; A N Srivastava; K M Singh
Journal:  J Indian Med Assoc       Date:  1994-11

2.  Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.

Authors:  I Bodrogi; M Baki; J Horti; L Géczi; G Liszka; S Ottó; I Hindy; S Eckhardt; J Sugár
Journal:  Acta Med Hung       Date:  1994

3.  [Cancer of the testis in cryptorchidism. Apropos of 5 cases].

Authors:  M Njeh; M Belhadj; J Mnif; A Bahloul; R Jlidi; M S Krichen; M N Mhiri
Journal:  J Urol (Paris)       Date:  1995

Review 4.  [Cryptorchidism and testicular cancer].

Authors:  J G Pereira Arias; A Astobieta Odriozola; I Zabalza Estévez; C Bernuy Malfaz
Journal:  Arch Esp Urol       Date:  1995-11       Impact factor: 0.436

5.  Stage I testicular seminoma: results of adjuvant irradiation and surveillance.

Authors:  P Warde; M K Gospodarowicz; T Panzarella; C N Catton; J F Sturgeon; M Moore; P Goodman; M A Jewett
Journal:  J Clin Oncol       Date:  1995-09       Impact factor: 44.544

6.  Prognostic value of BHCG and local tumor invasion in stage I seminoma of the testis.

Authors:  B F Schwartz; R Auman; S J Peretsman; J W Moul; G E Deshon; J Hernandez; R A Rozanski; J B Thrasher
Journal:  J Surg Oncol       Date:  1996-02       Impact factor: 3.454

7.  Radiotherapy for stages I and II testicular seminoma: results and morbidity in 238 patients.

Authors:  K A Vallis; G C Howard; W Duncan; M A Cornbleet; G R Kerr
Journal:  Br J Radiol       Date:  1995-04       Impact factor: 3.039

  7 in total
  1 in total

1.  Cisplatin-based chemotherapy for advanced seminoma: report of 52 cases treated in two institutions.

Authors:  Mountzios Giannis; Bamias Aristotelis; Koutsoukou Vassiliki; Anastasiou Ioannis; Stravodimos Konstantinos; Antoniou Nikolaos; Papadopoulos Georgios; Pavlakis Georgios; Papassavas Pantelis; Dimopoulos Meletios-Athanasios
Journal:  J Cancer Res Clin Oncol       Date:  2009-05-13       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.